Oncology PracticeTwitter storm over ‘reprehensible behavior’ at conference podiumFebruary 22, 2022Genitourinary Cancer
HR-positive BC: Sulindac relieves musculoskeletal symptoms in patients receiving aromatase inhibitorsFebruary 22, 2022Breast Cancer
HER2-negative BC: Better pathological response with nab-paclitaxel vs. docetaxel in real worldFebruary 22, 2022Breast Cancer
Early breast cancer: Adding capecitabine prolongs survival in 15-year FinXX trialFebruary 22, 2022Breast Cancer
Breast cancer: Fosnetupitant safe in patients receiving AC/EC chemotherapyFebruary 22, 2022Breast Cancer
ER+ BC: Reduced recurrence with aromatase inhibitors vs. tamoxifen in premenopausal womenFebruary 22, 2022Breast Cancer
Breast cancer: PTV of 9 susceptibility genes could guide gene panel testing and risk predictionFebruary 22, 2022Breast Cancer
Adding capecitabine to adjuvant chemotherapy improves RFS in non-BRCA1-like early TNBCFebruary 22, 2022Breast Cancer
TNBC: Adding carboplatin to neoadjuvant chemotherapy provides long-term EFS benefitFebruary 22, 2022Breast Cancer
Pyrotinib+capecitabine shows promise for HER2+ metastatic breast cancer and brain metastasesFebruary 22, 2022Breast Cancer
Hematology NewsSubvariant may be more dangerous than original Omicron strainFebruary 22, 2022COVID-19 Updates
Oncology PracticeSpironolactone not linked to increased cancer risk in systematic review and meta-analysisFebruary 22, 2022Mixed Topics
Hematology NewsIvermectin does not stop progression to severe COVID: randomized trialFebruary 22, 2022COVID-19 Updates
Hematology NewsEarly in career, female academic docs earn less than males: studyFebruary 22, 2022Diversity in MedicineBusiness of Medicine
